Aurélie Catteau
82 works · 1,874 citations · h-index 18
Top works
- Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics
- BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
- BRCA1 methylation: a significant role in tumour development?
- Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
- Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
- A population and family study of CYP1A2 using caffeine urinary metabolites
- Trends in Incidence, Risk Factors, and Survival in Symptomatic Lacunar Stroke in Dijon, France, From 1989 to 2006
- Transient Ischaemic Attack Mimics Revealing Focal Subarachnoid Haemorrhage
- Genomic grade adds prognostic value in invasive lobular carcinoma
- A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
- Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer
- Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
- A short region of the promoter of the breast cancer associated PLU-1 gene can regulate transcription in vitro and in vivo
- 491P Neoadjuvant nivolumab in early stage colorectal cancer
- FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable metastatic colorectal cancer (mCRC): Updated and overall survival results of the phase II randomized AtezoTRIBE study.
- Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study
- SO-28 FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable mCRC patients: Updated and overall survival results of the phase II randomized AtezoTRIBE study
- Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
- Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
- Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse